AngioDynamics, Inc. (ANGO) Tops Q2 EPS by 1c, Guides FY
AngioDynamics, Inc. (NASDAQ: ANGO) reported Q2 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $87 million versus the consensus estimate of $87.4 million.
AngioDynamics, Inc. sees FY2013 EPS of $0.40-0.42, versus the consensus of $0.40. AngioDynamics, Inc. sees FY2013 revenue of $355-360 million, versus the consensus of $359.75 million.
For earnings history and earnings-related data on AngioDynamics, Inc. (ANGO) click here.
AngioDynamics, Inc. sees FY2013 EPS of $0.40-0.42, versus the consensus of $0.40. AngioDynamics, Inc. sees FY2013 revenue of $355-360 million, versus the consensus of $359.75 million.
For earnings history and earnings-related data on AngioDynamics, Inc. (ANGO) click here.